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Background: Immunosenescence, ageing related decline in immunity, leads to 
increased incident and severity of various infections, reactivation of latent viruses and 
decline in vaccine responses among the elderly. As the proportion of older population 
is rising sharply across the globe, fundamental understanding of immunosenescence 
is vital for prevention, control and treatment of ageing-related diseases among the 
vulnerable population. Cytomegalovirus (CMV) plays a substantial role in 
acceleration of immunosenescence. Interestingly, HERV-K (HML-2), the youngest 
group of human endogenous retroviruses, has been shown to be co-expressed with 
CMV in several diseases and cancers. Thus, it is rational to hypothesize that HERV-K 
(HML-2) potentially plays role in immunosenescence. 
Subjects and methods: We investigated potential role of HERV-K (HML-2) in 
immunosenescence using whole genome RNA-sequencing technique with seven 
young subjects, age=26-32 years and seven older subjects from Vitality 90+ study 
cohort, age=90+ years. Gene set enrichment analysis (GSEA) was used to elucidate 
young and older group specific profile of gene ontology (GO) based biological 
processes. Direction (up or down) of regulation of the significant biological processes 
among older subjects was investigated with differential gene expression and 
subsequent over-representation analysis. Genes that were highly correlated 
(correlation > 0.80 or < -0.80) with HERV-K expression were used for over-
representation analysis with GO based biological processes. 
Results and Conclusion: Gene set enrichment analysis of nonagenarian and young 
groups identified significantly large number of biological processes enriched in 
nonagenarian as compared to young subjects. Differential gene expression analysis 
identified 347 genes highly correlated with the youngest provirus, 1q22 that were also 
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differentially expressed between the nonagenarian and young groups. Over-
representation of those genes uncovered several immunity related genes and 
biological processes associated with provirus 1q22 among older subjects. Therefore, 
our results indicate that provirus 1q22 could be a potential player in 
immunosenescence. Further research with larger datasets with gender variation is 
needed for deeper understanding. 
 
Keywords: Immunosenescence, HERV-K (HML-2), provirus 1q22, cytomegalovirus, 
differential gene expression, enrichment analysis, over-representation analysis 
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1 INTRODUCTION 
The global population is ageing. In 2017, almost 962 million people (~13% of the 
global population) worldwide were 60 years or older. By 2050, people aged 60 or 
older is expected to increase to 2.1 billion and 3.1 billion in 2100 (United Nations 
Department of Economic and Social Affairs, 2017). One of the emerging problems 
due to ageing of population is increased vulnerability to infectious diseases as 
compared to the younger population. Studies have demonstrated that mortality rate 
increases 89-fold for pneumonia and influenza and 43-fold for cancer in people aged 
65 in western countries (Bulati, Pellicanò, Vasto, & Colonna-Romano, 2008). 
Understanding and preventing these infections, thus, becomes important to public 
health care system. The most important cause for increased rate of infection and 
cancers in elderly population is due to diminished immunity. Deterioration of 
immunity due to ageing is known as immunosenescence. Immunosenescence leads to 
increased incident and severity of various infections, reactivation of latent viruses and 
decline in vaccine responses among the elderly. With the surge in proportion of older 
population across the globe, immunosenescence is emerging public health problem. 
Fundamental understanding of immunosenescence is thus vital for prevention and 
treatment of ageing-related diseases.  
 
Immunosenescence affects both adaptive and innate immune system. However, innate 
immune system seems to be less affected by age. Markers of immunosenescence 
include decrease in naive T cell exiting thymus and declining function of 
haematopoietic cell. Naive T cell in the elderly shows numerous defects such as 
reduced interleukin-2, shorter telomeres, and restricted T cell receptor repertoire. 
Evidence suggests that epigenetic changes such as histone acetylation and DNA 
methylation accumulate with ageing contributing to immunosenescence (Ponnappan 
& Ponnappan, 2011).  
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Whether or not immunosenescence is a result of an adaptive response to infections is 
an open question. Evidences show that chronic T cells activation due to persistent 
viral infection in immune-competent hosts can potentially influence T cells (Aiello, 
Chiu, & Frasca, 2017). The most common pathogen known to induce 
immunosenescence is CMV (Pawelec, Derhovanessian, Larbi, Strindhall, & Wikby, 
2009; Pawelec, Solana, & Wikby, 2005). Several studies have shown that HERV-K 
(HML-2) to be co-expressed along with CMV in many diseases (Assinger, Yaiw, 
Göttesdorfer, Leib-Mösch, & Söderberg-Nauclér, 2013; Bergallo et al., 2015). This 
raises interest in whether or not HERV-K (HML-2) is also involved in 
immunosenescence. The focus of this study is to investigate potential role HERV-K 
(HML-2) proviruses in immunosenescence. 
 
HERV proviruses comprise about 8% of the human genome (Bannert & Kurth, 2004). 
The proviruses integrated themselves into human genome through infection long ago. 
Through the evolutionary period, the proviruses have accumulated mutations that have 
disabled them to produce infections. HERV-K(HML-2) are understood to be the 
youngest HERV family (less than 5 million years) that contains a complete set of 
genes (albeit defective due to mutations) (Bannert & Kurth, 2004; Dewannieux et al., 
2006). Their expression has also been associated with breast and bladder cancer, 
sarcoma, malignant melanoma and lymphoma (Cegolon et al., 2013). Understanding 
their role in human diseases could establish them as a probable therapeutic targets as 
they  represent virus-like tumour antigens (Assinger, Yaiw, Göttesdorfer, Leib-Mösch, 
& Söderberg-Nauclér, 2013). However, unlike CMV, association of HERV-K 
proviruses with immunosenescence has not been well studied.  
 
We studied role of HERV-K proviruses in immunosenescence using whole genome 
RNA-sequencing technique with young healthy laboratory subjects (seven female 
between 26-32 years) and seven subjects from Vitality 90+ study cohort (seven female 
between 90-99 years). We performed gene set enrichment analysis (GSEA) to identify 
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young and older group specific Gene Ontology (GO) (Ashburner et al., 2000) based 
biological processes that are significantly associated with the proviruses. This 
approach, however, is not sufficient to elucidate the important question of whether 
biological processes are up or downregulated among older subjects. For that, 
differential gene expression analysis was done between young and nonagenarian 
groups (age of 90 and 99). We focused on only those genes that are correlated 
(correlation >0.80 or <-0.80) with the differentially expressed proviruses. We then 
performed over-representation analysis to identify significantly enriched GO 
biological processes. The study identified several immunity related genes and 
biological processes significantly associated with HERV-K provirus 1q22. Our results 
suggest that provirus 1q22 is potential player in mediating immunosenescence. 
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2  LITERATURE REVIEW 
The focus of the study is to elucidate potential role of HERV-K (HML-2) provirus in 
immunosenescence. Therefore, in literature review, factors that effects 
immunosenescence in elderly will be focused. As immunosenescence is deterioration 
of immunity with age, information on ageing and its cellular and molecular 
manifestations is important to discuss. Following that, relation of inflammaging and 
immunosenescence will be briefly discussed. Types of immunity is important to 
discuss as immunosenescence affect both adaptive and innate immune system in 
different forms.  Clinical implication of immunosenescence is important to be 
discussed, as it will explain the need to investigate more on immunosenescence. 
Immunosenescence has been known to be induced by pathogens like CMV. 
Furthermore, HERV-K has been shown to be co-expressed with CMV in several 
diseases and cancers. Therefore, HERV-K (HML-2) was chosen as pathogen of 
interest as there has not been any research done to investigate its role in 
immunosenescence.  
 
 
2.1 Ageing 
 Ageing is defined as progressive deterioration of physiological ability leading to age-
related mortality and decrease in the age related reproductive rate (Kirkwood, 1995; 
López-Otín, Blasco, Partridge, Serrano, & Kroemer, 2013; Rose, 1991).  However, it 
is largely determined by genetics, environmental factor such as diet, exercise, 
exposure to microorganism, pollutants, and ionizing radiation (Sorrentino, Sanoff, & 
Sharpless, 2014). Hence, ageing occurs in different degrees in different individuals. 
Women live longer than men worldwide, indicating that longevity of life seems 
strongly influenced by gender (Sorrentino et al., 2014).  
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2.2 Cellular and Molecular manifestation of ageing 
Several theories and mechanisms interpret the process and consequences of ageing.  
Due to the multiclausal dimension of ageing process, just one theory cannot not 
explain all its mechanism. López-Otín et al., 2013 have come up with nine cellular 
and molecular hallmark of ageing which together determine the ageing phenotype 
(Figure 2 -1). 
 
 
 
 
 
Figure 2-1 Hallmarks of Ageing ( López-Otín et al., 2013). 
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2.3 Inflammaging 
Inflammaging is illustrated as a chronic, low-grade, systemic inflammation that 
develop with age and are associated with frailty and mortality in elderly (Franceschi & 
Campisi, 2014). Studies revealed that during mild inflammation, levels of various pro 
inflammatory cytokines like interleukin 6 (IL-6), C-reactive protein (CPR), TNF-α 
and IFN- γ are elevated. This is associated and is predictive of many ageing 
phenotypes such as immune senescence, metabolic homeostatic, energy production 
and utilization and neuronal health (Franceschi & Campisi, 2014). The aetiology of 
inflammaging remain largely unknown. Acute inflammation has beneficial effect 
towards the neutralization of harmful pathogens during early life and adult. However, 
acute inflammatory response to pathogens become detrimental during ageing leading 
to increase susceptibility to infection. 
 
Franceschi & Campisi, 2014 summarized the source of inflammaging into five 
following categories as, 
i) destroyed cells and macromolecules that accumulate with age 
ii) cellular senescence and secretion of proinflammatory cytokines 
iii) immunosenescence that can be initiated by persistent infection such as CMV 
iv) activation of the coagulation system with age and 
v) harmful products and metabolites produced by oral or gut microbes that decreases 
with age.  
 
 
2.4 Immunosenescence 
Immunosenescence refers to the age-associated deterioration of the immune system 
(Boraschi & Italiani, 2014; Fülöp, Fóris, Wórum, & Leövey, 1985). This contributes 
to increasing levels of infection and poor response to vaccinations, as well as diseases 
like cardiovascular disease and cancer. Immunosenescence is also likely to contribute 
to inflammaging (Franceschi & Campisi, 2014).Immunosenescence leads to an 
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increased number of pro-inflammatory cytokine-producing cells like inflammatory 
cells. In addition, chronic inflammatory conditions can accelerate the 
immunosenescence process (Franceschi & Campisi, 2014). Inflammatory cells and 
immune cells have the same cellular foundation. Hence, Inflammaging and 
immunosenescence are connected and coexist, and is difficult to differentiate whether 
the inflammation-related diseases are caused by inflammaging or immunosenescence 
(Xia et al., 2016). Furthermore, internal relationship between inflamm-ageing and 
immunosenescence is not known, and the causes and pathological mechanisms of 
immune-inflammatory diseases are not understood. In addition, changes in adaptive 
and innate immunity is different with age. Adaptive immunity declines with age 
unlike innate immunity that will undergo minor changes that might cause mild 
hyperactivity. Furthermore, with age, adaptive immune system might give burden to 
the innate immunity. These changes are due to the lifelong exposure to pathogens and 
antigens such as CMV, human endogenous retrovirus, Epstein-Barr virus and intrinsic 
changes in immune cells and genetic predisposition (Franceschi, Bonafè, & Valensin, 
2000; McElhaney & Effros, 2009). Therefore, we will discuss into details the changes 
in innate and adaptive immune system with age. 
 
2.5 Changes in innate immune system 
The innate immune system is the initial response of defense against pathogens. With 
age, there is compromised function in epithelial cells of the skin, lung, or gastro-
intestinal tract, which facilitates pathogens to invade mucosal membrane resulting in 
health-related challenges among elderly. The innate immune system consists of 
phagocytic cells (neutrophils, and monocytes/macrophages, and dendritic cells), 
natural killer cells and soluble mediators like natural cytokines, chemokines, 
hormones, and oxygen-free radicals.  
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2.5.1 Neutrophils 
Neutrophils are short-lived cells. They act as a host defense mechanism to bacterial, 
fungal infections and during acute inflammation. Neutrophils ingest pathogenic 
organism by phagocytosis. Generation of reactive oxygen species (ROS) and toxic 
granular enzymes work together to kill the ingested pathogens. (Lehrer et al., 1988). 
Neutrophils are recruited to the infection site  by cytokine and chemokine mainly by 
IL-1 and IL-8(Lehrer, Ganz, Selsted, Babior, & Curnutte, 1988; Sica et al., 1990). 
Various studies showed no change in the number of circulating neutrophils with age 
(Chatta & Dale, 1996; Shekarabi & Asgari, 2014). However, neutrophils retrieved 
from elderly are less phagocytic than those from younger individuals (Butcher, 
Chahel, & Lord, 2000; Fülöp, Fóris, Wórum, & Leövey, 1985).  Neutrophils also 
promote the maturation and migration of DC that will trigger the adaptive immune 
response (Solana, Campos, Pera, & Tarazona, 2014).  
 
2.5.2 Natural killer cell 
Natural killer (NK) cells are cytotoxic cell that play a major role in the elimination of 
virus-infected cells or tumor cells. It also helps in the regulation of the immune 
response by producing cytokines and chemokines that can stimulate cellular 
components of innate and adaptive immunity (Campos et al., 2014; Weiskopf, 
Weinberger, & Grubeck-Loebenstein, 2009). Evidence has shown the importance of 
NK cell activity in retaining health in ageing individual. Studies have reported that 
high NK cytotoxicity to be associate with healthy ageing and longevity (Solana & 
Mariani, 2000), whereas low NK cytotoxicity to be associated with increased 
morbidity and mortality due to infections, in elderly (K. Ogata et al., 2001). Other age 
related changes in NK include increased rate of rejuvenation of latent Mycobacterium 
tuberculosis (Pietilä et al., 2015) and slower resolution of inflammatory responses. 
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2.5.3 Macrophages 
Macrophages trigger adaptive immune responses against pathogens by acting as 
antigen-presenting cells. Macrophages acts on the tissues in which they reside 
(Gomez, Nomellini, Faunce, & Kovacs, 2008). Macrophages are involved in 
phagocytosis of antigens and cellular debris and killing of invading pathogens and 
tumors through oxygen-dependent and independent mechanisms(Gomez et al., 2008). 
Furthermore, macrophages also secrete cytokines, which regulate multiple immune 
functions, specifically inflammatory responses. With age, antigen representation by 
macrophages is decreased likely due to decrease levels of MHC class II molecules 
(Plowden, Renshaw-Hoelscher, Engleman, Katz, & Sambhara, 2004; Zissel, Schlaak, 
& Muller-Quernheim, 1999). A study has shown decreased chemotaxis and defective 
phagocytosis in macrophages from elderly humans and mice. (Fietta et al., 1993). 
With age, macrophages significantly reduce secretion of cytokines such as TNF-α  and 
IL-6  and  decrease  B7  receptor  expression, which  activates T  cell (Davalos, 
Coppe, Campisi, & Desprez, 2010; van Duin et al., 2007). 
 
2.5.4 Dendritic cells 
 Dendritic cells (DC) are the key component in linking the bridge between innate and 
adaptive immunity. DC are responsible for the first recognition of T and B 
lymphocytes and NK cell. Studies have reported that there will be decrease in the 
Langerhans cells in skin and plasmocytes with age (Agrawal et al., 2007). DC from 
healthy elderly is able to retain their capacity to efficiently activate antigen to T cells 
(Lung et al., 2000). However, expression of costimulatory molecules and IL-12 
production is decreased in frail elderly and hence, have impaired ability to activate T 
cell proliferation (Lung, Saurwein-Teissl, Parson, Schönitzer, & Grubeck-
Loebenstein, 2000). Furthermore, antigen-presenting capacity of aged plasmacytoid 
dendritic cell of elderly showed reduced capacity to activate T cell proliferation and 
IFN- γ secretion in CD4 and CD8 T cells as compared with plasmacytoid dendritic 
cell from young adults. 
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Table 2-1 Age related changes in innate immune system 
Cell type effect of ageing 
Neutrophil  reduces chemotaxis and phagocytosis 
reduces superoxide anion production 
reduces activation signal transduction 
reduces production of IFN- γ 
Macrophage reduces phagocytosis 
reduces cytokine and chemokine secretion 
delayed wound healing 
Diminished TLR expression and function 
 
Natural killer cell  decreases cytotoxic capacity 
decreases secretion of IFN- γ 
decreases response to IL-2 
 
Dendritic cell decreases ability to stimulate lymphocytes 
reduces chemotaxis 
decreases capacity to stimulate antigen specific T cell 
 
 
 
 
2.6 Changes in adaptive immune system 
Adaptive immune system is composed of the cellular immune response that is T 
lymphocytes, and the humoral immune response, which is the B lymphocytes.  
 
2.6.1 B Lymphocytes 
B lymphocytes develop in bone marrow and continues in the spleen for final 
maturation. B lymphocytes are responsible for the production of antibodies in 
response to infections. Number of peripheral B cell do not decline with age but the 
composition of the cell changes. The percentage of naïve B cells, accompanied with 
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the absence of CD27 cell, is significantly reduced with age. With age, there is 
defective in the production of antibody and impaired B cell responses. This will 
adequately reduce the ability to respond against pathogens (Buffa et al., 2011; 
Visentini et al., 2011). Furthermore, research showed that the antibody response 
against hepatitis vaccines was diminished dramatically in elderly adults (mean age 61 
years) compared with a young adults (mean age of 33 years) (Rosenberg et al., 2013). 
Serum immunoglobulin levels are stable in elderly individual, however, the anti-
bodies secretion in old age are of lower affinity because of antibody isotypes  shift 
from IgG to IgM (Rosenberg et al., 2013). 
 
2.6.2 T Lymphocytes 
T lymphocyte develop in thymus. Thymus is most active in the early years, reaches 
peak size within the first year and undergoes decline with age almost complete by the 
age of 75.(George & Ritter, 1996) . This process is called involution. During  
involution, there is reduction of  overall size of thymus and a replacement of the 
functional cortex and medulla tissue by fat and  increase in volume of the perivascular 
space of human thymus with age (Flores, Li, Sempowski, Haynes, & Hale, 1999). 
This process results in decrease in the number of naïve T cells existing from thymus , 
which in turn reduces T-cell receptor diversity (Chou & Effros, 2013). This decrease 
in the naïve T- cell output is linked with the increased incidence of infections, cancers 
autoimmune diseases (Palmer, 2013). Furthermore, studies have suggested that naïve 
T cell of elderly individuals have numerous functional defect such as shorter telomere, 
restricted T cell receptor repertoire and reduced interleukin-2 production with 
compassion with younger adults (Kohler et al., 2005; Pfister et al., 2006). Shortening 
or sequential loss of telomeric DNA increases apoptosis with age (Aggarwal & Gupta, 
1998). Shortening of telomere is linked to various diseases associated with ageing like 
diabetes, hypertension, Alzheimer's disease and cancer (Rizvi, Raza, & Mahdi, 2014). 
However, naïve T cell in elderly is associated with increased number of antigen-
encounter memory cell, particularly effector T cells. This effector T-cell shows 
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phenotypic changes of co-stimulatory molecule such as CD28, which is said to be a 
predictor of immune incompetence in elderly (Vallejo, 2005).  
 
 
 
Table 2-2 Age related changes in adaptive immune system 
 
Cell type Effect of Ageing 
T- lymphocyte decreases in CD4+/CD8+ lymphocyte 
decreases in membrane receptor 
increases release of pro-inflammatory 
cytokines like IL-1,IL-6 and TNF- α  
 
B -lymphocyte decreases in antibody production 
decreases in lymphocyte number 
decreases in production of IL-2 
increases in Autoreactive serum antibodies 
 
 
 
 
 
 
2.7 Clinical implications of immunosenescence 
 
The clinical implications of immunosenescence include increased risk of infections, 
malignancy, autoimmune disorder, atherosclerosis and various neurodegenerative 
disorder. This is due to various mechanism discussed in previous chapters. With 
understanding of the mechanism of immune system, efficient vaccines and novel 
therapies could be developed to restore appropriate immunity treat or prevent these 
conditions by identifying the exact components to manipulate as needed. Therefore, 
understanding immunosenescence help to increase healthy life span of individual 
during old age. 
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2.7.1 Vaccination 
 
Elderly people are susceptible to morbidity and mortality from infectious disease 
globally. Deaths among elderly due to pneumonia is twice as high and from 
tuberculosis is ten-folder higher compared with the young adults. Elderly people have 
less circulating monocytes and dendritic cells than that of young individuals. 
Furthermore, there is also fewer tissues associated with dendritic cells and 
macrophages and increased splenic dendritic cells. In addition, there is decrease in 
the population of naïve T and B cells with increase in mature T and B cells. Due to 
this, overall antibody production and specificity is significantly diminished in the 
elderly. There are vaccines to minimize the mortality from infectious condition, 
however, immunosenescence hinder the ability to develop immunity after vaccination 
in elderly. Vaccination will activate immune response in both humoral and cell 
mediated immunity. The effectiveness of vaccine depends on the immune response, 
therefore, immunocompromised individual such as elderly are at high risk of being 
inadequately protected by certain vaccine. Studies have demonstrated that the ability 
of influenza vaccine to induce protection depends on age (P. O. Lang et al., 2010; 
Pierre Olivier Lang, Govind, Mitchell, Siegrist, & Aspinall, 2011). It showed that 
efficacy of vaccine is between 70% and 90% in those under 65 years of age, but it 
was only 30–40% for those over 65 years of age. Thus, the current vaccines are less 
immunogenic and less efficient for the elderly. To develop effective vaccines for the 
65+ population requires clear understanding of mechanism to stimulate a cell-
mediated response that increases the protection in elderly population.  
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Figure 2-2 Elements of the immune response necessary to mount a response to 
vaccination in young and old (Bowdish, Loukov, & Naidoo, 2015). 
 
2.7.2 Cancer 
The incidence and prevalence of most cancers is higher with age (Thakkar, 
McCarthy, & Villano, 2014).  Incidence of cancer in those over 65 is 10 times higher 
than in those younger (Thakkar et al., 2014). About 60% of all cancers and 70% of 
mortality due to cancer occur in people older than 65 years. Relation between ageing 
and cancer is not well- understood considering the existence of multiple different 
cancers. However, one of the reason to explain the incidence of cancer in older age is 
immunosenescence. It has been suggested that inflammatory markers increase with 
age, while immunological surveillances is less effective (Hoffe & Balducci, 2012). 
This could promote the growth of immunogenic tumors with age. Furthermore, 
diminished proliferation response and cytotoxicity of natural killer cells could also 
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increase the risk of tumor cells in elderly (Imai, Matsuyama, Miyake, Suga, & 
Nakachi, 2000). 
 
 
There was fourteen million new cancer cases worldwide in 2012, and  2.2 million 
(15.4%) were due to infection (Plummer et al., 2016). Several infectious agents are 
considered to cause cancer, for example; Helicobacter pylori, hepatitis B virus, 
hepatitis C virus, human papillomavirus, Epstein-Barr virus, CMV, human 
herpesvirus and recently Human endogenous retrovirus. Cancer will remain a major 
cause of death around the world. Fraction of human cancer would be expected to be 
in control by preventing infection associated cancers (de Flora & Bonanni, 2011). 
However, further studies are needed to understand the underlying mechanism 
between infectious pathogens and cancer.  
 
 
 
2.8 Human endogenous retroviruses (HERVs) 
HERVs are remnants of ancient retrovirus infections that have been integrated into 
DNA via infection of germline cell. They are transmitted vertically through germline 
and through generations in a Mendelian manner. HERVs comprise about 8% of the 
human genome (Bannert & Kurth, 2004). There are more than 30 HERV families that 
have been identified during past two decade (Tristem, 2000). Through the 
evolutionary period, HERVs have accumulated mutations, deletions, termination 
signals within coding sequences that have disabled limited number of HERV to 
produce infections. However, a number of HERVs have intact open reading frames 
that code for functional proteins. HERVs are part of retrotransposon families or 
“jumping genes” within the human genome (Bannert & Kurth, 2004). Transposable 
elements may also be able to affect the function and expression of nearby genes 
depending on where they locate themselves in the genome. HERVs have frequently 
been proposed as etiological co-factors in chronic diseases such as cancer, 
autoimmunity and neurological disease (R. P. Subramanian, Wildschutte, Russo, & 
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Coffin, 2011). However, the causal relationship remains enigmatic (Nelson et al., 
2004). HERV-K (HML-2) is understood to be the youngest HERV family (less than 5 
million years) that contains a complete set of genes (albeit defective due to mutations) 
(Bannert & Kurth, 2004). 
 
2.8.1 HERV-K (HML-2)  
HERV-K (HML-2) (will be referred as HERV-K hereafter) is the newest of the 
HERV-K family (Barbulescu et al., 1999). Therefore, has had the least time to acquire 
mutations and comprises the most preserved set of retrovirus in the human genome (R. 
P. Subramanian et al., 2011). The “K” from HERV-K comes from the use of lysine 
tRNA to prime reverse transcription and (HML-2) comes from their relationship to 
their pol sequence to mouse mammary tumor virus, a causative agent for breast cancer 
in mice (Bittner, 1936). HERV-K is the only known HERV that is capable of 
expressing viral proteins and viral like particles. HERV-K contains more than 90 
proviruses and around 950 long terminal repeats (LTRs) produced from recombination 
between the 5’ and 3’ LTRs of a provirus (Hughes & Coffin, 2004).  More than 90 
proviruses of the HERV-K family have intact and well preserved  open reading frames 
in genes which sometimes encode for functional proteins that are expressed in various 
tissues (R. P. Subramanian et al., 2011). Some HERV-K has also maintained open 
reading frames for retroviral gene such as gag, pro, pol and env. 
 
HERV-K is expressed at only very low levels in healthy tissues (Hohn, Hanke, & 
Bannert, 2013). Studies indicated that increased HERV- K expression to be linked 
with several diseases in humans. Diseases such as breast cancer (Bittner, 1936; Golan 
et al., 2008; Ono, Kawakami, & Ushikubo, 1987), germ cell tumor(Golan et al., 2008; 
Sauter et al., 1996), melanoma (Büscher et al., 2005; Hahn et al., 2008; Muster et al., 
2003), ovarian cancer(Wang-Johanning et al., 2007), leukemia(Depil, Roche, Dussart, 
& Prin, 2002; Iwabuchi et al., 2004), schizophrenia (Huang et al., 2006; Karlsson et 
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al., 2001; Slokar & Hasler, 2016), rheumatoid arthritis (Freimanis et al., 2010; Reynier 
et al., 2009) as well as during HIV infection (Contreras-Galindo et al., 2012; 
Gonzalez-Hernandez et al., 2012; van der Kuyl, 2012). Various studies demonstrated 
the elevated expression level of HERV-K antibodies in blood of patients at early stage 
of cancer (Büscher et al., 2006; Karreth et al., 2011; Muster et al., 2003; Wang-
Johanning et al., 2013). Therefore, presence of antibodies specific for HERV-K 
proteins could be promising additional diagnostic and prognostic approach towards 
these types of cancers (Kleiman et al., 2004). 
 
Table 2-3List of malignant diseases that are associated with HERV-K activity. 
Tissues cancers HERV-K 
Breast Breast cancer Retroviral activity 
Virus particles 
Free viral RNA 
 
Skin Melanoma Retroviral activity 
Enhanced transcription 
Retroviral particles 
 
Testes Germ cell tumors Expression of Rec,Np9 
Ovary Ovarian cancer Expression of Gag and Env 
Prostrate Prostate cancer Expression of gag  
Blood Lymphoma Free RNA 
Retroviral activity 
Virus particles 
 
Until recently, HERV-K are related with induction of various diseases. However, 
Kleiman et al., 2004 suggested that targeting of neoplastic cell could be novel 
therapeutic approach to cure cancer. The authors suggested that reactivation and 
expression of HERV-K in healthy tissue might affect cellular physiology by activating 
HERV-K promotors that act on genes on cellular level. However, further investigation 
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on curing cancers by activating HERV-K to activate innate immune response is 
necessary. 
 
Furthermore, it was shown that HERV-K expression can also be activated by EBV 
(Hsiao, Lin, Tai, Chen, & Huber, 2006; Sutkowski, Chen, Calderon, & Huber, 2004; 
Sutkowski, Conrad, Thorley-Lawson, & Huber, 2001), human herpesvirus (Tai, Luka, 
Ablashi, & Huber, 2009; Turcanova, Bundgaard, & Höllsberg, 2009) and human 
CMV (Assinger et al., 2013; Bergallo et al., 2015). 
 
 
2.9  HERV-K and Cytomegalovirus 
Human CMV infection infect 40-100% of human population globally (Jean Beltran & 
Cristea, 2014). After primary infection, CMV establish itself in some form in 
hematopoietic stem cells (Sindre et al., 1996). The mechanism in which CMV persists 
in human is still a poorly understood because it rarely causes problems in healthy 
people. CMV usually causes asymptomatic or mild infection in healthy individuals, 
but may cause severe and life-threatening conditions in immunocompromised 
individuals (Lancini, Faddy, Flower, & Hogan, 2014). CMV has been detected in 
various cancers such as, medulloblastoma, neuroblastoma, colon, breast and prostate 
cancer (Cobbs, Soroceanu, Denham, Zhang, & Kraus, 2008; Harkins et al., 2002, 
2010; Samanta, Harkins, Klemm, Britt, & Cobbs, 2003). Studies have suggested that 
CMV and an inflammatory environmental condition could facilitate HERV-K 
activation in vivo in early tumor lesions (Assinger, Yaiw, Göttesdorfer, Leib-Mösch, 
& Söderberg-Nauclér, 2013; Bergallo et al., 2015). Furthermore, it has shown that 
HERV-K expression could be induced by several cytokines and growth factors 
induced by reactivation of CMV (Assinger et al., 2013). 
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Studies have suggested that persistent CMV infection initiates immunosenescence 
(Pawelec et al., 2009, 2005). One hallmark of latent CMV infection is substantial 
increment in number of CMV specific memory CD8+ T cells and decrease in CMV 
specific memory CD4+ T cells over time (Weltevrede, Eilers, de Melker, & van 
Baarle, 2016). This process of accumulation of CMV specific memory T cell during 
viral infection is known as memory inflation (Karrer et al., 2003).  It has been 
suggested that CMV infection is linked with clonal extension of CD8+ T cells, an 
inverted CD4 to CD8 and increased numbers of CD8+CD28− T cells (Wikby et al., 
2002).  Furthermore, CMV infection may also inhibit the natural killer cell mediated 
lysis of infected cells (Wills et al., 2005) and modulates the natural killer cells 
receptor repertoire of natural killer and T cells (Gumá et al., 2004). In addition, 
several cross-sectional studies have reported that CMV has less effect on the naïve T 
cell pool than that of memory T cells (Mekker et al., 2012; Wertheimer et al., 2014).   
 
 
2.10 HERV-K and Epstein Barr Virus 
EBV infects 90% of the world’s population. EBV is the first human virus related to 
oncogenesis (Epstein, Achong, & Barr, 1964). After initial primary infection, most 
individuals remain  lifelong carriers of the disease without serious symptoms (Orem, 
Mbidde, Lambert, De Sanjose, & Weiderpass, 2007). Unlike CMV, EBV is not 
associated with immunosenescence (Geng & Wang, 2015). The important clinical  
impact of EBV infected people is an increased risk of lymphoproliferative disorders 
(Geng & Wang, 2015). However, various study suggested that EBV transactivates 
HERV-K (Hsiao et al., 2006; Sutkowski et al., 2004, 2001). Sutkowski et al., 2001 
revealed that EBV activates env of HERV-K18 that possesses superantigen activity. 
Other viruses which are also been detected in various cancer along with CMV and 
HERV-K and EBV are Hepatitis B and C, human papillomavirus, human herpes virus 
8 (Morales-Sánchez & Fuentes-Pananá, 2014; Parkin, 2006). 
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This study investigates whether or not HERV-K play a role in immunosenescence. We 
performed gene set enrichment analysis (GSEA) (also called as pathway analysis) to 
identify various biological processes/pathways that are significantly associated with 
HERV-K proviruses in nonagenarians. Group of seven young subjects will be used as 
control. 
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3 AIM AND OBJECTIVES 
3.1 Aim 
To investigate the role of HERV-K in immunosenescence and its underlying 
mechanisms. 
 
3.2 Objectives 
 
1. Identification of nonagenarian specific biological processes that are highly 
associated with HERV-K proviruses. 
 
2. Identification of differentially expressed genes and HERV-K proviruses between 
nonagenarian and young control. 
 
 
3. Identification of directionality (up or down-regulation) of significant biological 
processes through differential gene expression analysis between older and young 
subjects followed by over-representation analysis.  
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4 MATERIALS AND METHODS 
4.1 Study populations 
Study population consisted of seven young healthy laboratories personal aged between 
26 and 32 (median 28) and seven nonagenarian (age 90-99) female from “The Vitality 
90+ study”. The decision to recruit seven individual is due to limited availability of 
funding resources. The recruitment and characterization of participants were 
accomplished as reported in the article by Goebeler, Jylhä, & Hervonen, 2003. A 
trained laboratory technician in the laboratory facilities collected blood samples.  
Blood samples were collected between 8:00 -12:00 am into EDTA containing tubes. 
Samples were directly placed into leucocyte separation on a Ficoll-Paque density 
gradient (Ficoll-Paque™ Premium (GE Healthcare Bio-Sciences AB, Uppsala, 
Sweden). Peripheral blood mononuclear cell (PBMC) layer was collected for RNA 
extraction and suspended in 150 μl of RNAlater solution (Ambion Inc., Austin, TX, 
USA). 
 
4.2 RNA extraction and sequencing 
RNA used for RNA sequencing was cleansed using a miRNeasy mini kit (Qiagen, 
CA, USA) following manufacturer’s protocol with on-column DNA digestion 
(Qiagen). The concentration and quality of the RNA was assessed with a NanoDrop 
ND-1000 spectrophotometer (NanoDrop Technologies, DE, USA). Agilent 
Bioanalyzer RNA nano chips (Agilent) were used to evaluate the integrity of total 
RNA and Qubit RNA –kit (Life Technologies) to quantitate RNA in samples. One µg 
RNA was used for ScriptSeq™ Complete Gold System (Epicentre) to ribodeplete 
rRNA and further for RNA-seq library preparation. SPRI beads (Agencourt AMPure 
XP, Beckman Coulter) were used for purification of RNAseq libraries. The library QC 
was evaluated on High Sensitivity chips by Agilent Bioanalyzer (Agilent). Paired-end 
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sequencing of RNAseq libraries was done using Illumina HiSeq technology with a 
minimum of 60 million-2x100bp paired-end reads per sample. 
 
4.3 Data pre-processing 
Raw reads were aligned to human genome reference build hg19 using TopHat v2.0.13 
(Trapnell, Pachter, & Salzberg, 2009)with default parameters. Only uniquely mapped 
reads were considered in the transcript abundance estimation and to this end 
SAMtools (Li, 2011) was used to filter out reads mapping to multiple regions of the 
genome. The downstream analysis was all conducted using the tools in cufflinks2 v. 
2.2.1 (Trapnell et al., 2012, 2013). The raw expression estimates were calculated using 
cuffquant and the expression were normalized using cuffnorm that gives the 
normalized read counts and the fragments per kilobase per million values (FPKM) for 
each gene as an output. The geometric normalization method was used which scales 
the read counts as well as the FPKM values according to procedure described 
(Hubbard et al., 2002).  The annotation data for HERV-K(HML-2) was from (A. 
Subramanian et al., 2005).To ensure the robustness of the normalization, the 
expressions of HERV-K (HML-2) elements were quantified and normalized together 
with ENSEMBL v. 82 gene reference set (Cunningham et al., 2015; Hubbard et al., 
2002).  
 
4.4 Ethical Consideration 
 Study participants provided written informed consent. This study followed principles 
expressed in the declaration of Helsinki. The use of blood samples from 
nonagenarians and healthy controls was approved by the Ethics Committee of city of 
Tampere. (1592/403/1996). 
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4.5 Data cleaning 
Only the genes and HERV-K proviruses that were expressed (normalized read count ≥ 
16) in at least four subjects in each group (nonagenarian and young) were included in 
analysis. Number of HERV-K proviruses and human genes that survived the filtration 
criteria were 22 and 15912 respectively. 
 
4.6 Gene Set Enrichment Analysis (GSEA) 
Analysis of nonagenarian specific biological processes significantly associated with 
HERV-K proviruses was done using GSEA (Aravind Subramanian et al., 2005) 
implemented in R package clusterProfiler (version3.7). The analysis was done 
separately for nonagenarian and young subjects. Pearson correlation coefficients were 
calculated between all HERV-K elements and human genes. Genes were ranked by 
their correlation coefficients and used as input for GSEA. The Gene Ontology (GO) 
based biological processes, standardized annotation of genes and gene products 
(Ashburner et al., 2000) was used as gene sets (referred as GO terms here onwards). 
GO terms with size ranging from 25 to 500 member genes were included in the 
analysis. Statistical significance of GO term enrichment scores was accessed by 
calculating empirical P-values with 10000 permutations. P-values were corrected for 
multiple testing with Benjamini & Hochberg method (Benjamini & Hochberg, 1995). 
 
4.7 Over-representation analysis 
GSEA analysis was done using correlation scores calculated between human genes 
and provirus to profile nonagenarian specific biological process related GO terms. The 
approach, however, is not sufficient to elucidate the important question of whether 
biological pathways are up or downregulated among nonagenarian. For that, 
differential gene expression analysis was done between young and nonagenarian 
groups. Genes with adjusted P-value < 0.05 were considered significantly 
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differentiated between the compared groups. We performed over-representation 
analysis with only those significant genes that are hightly correlated with HERV-K 
provirus 1q22 (cor < -0.80 or > 0.80). GOstats R package (Beißbarth & Speed, 2004) 
was used for the over-representation analysis. 
 
4.8 Methodological details 
The advancement in biotechnology has led to generation of high throughput biological 
data. The main challenge for analysing such data is getting meaningful biological 
conclusion. 
 
4.8.1 Gene expression 
Genes encode for protein and proteins are essential for cellular functions. There are 
thousands of genes expressed in each particular type of cell that determines function 
of that particular type of cell. Gene expression involves two steps called transcription 
and translation. When genes are expressed, the genetic information on DNA is first 
transcribed to messenger RNA (mRNA). The mRNA molecules are then translated to 
a series of amino acids to build desired proteins. Regulation of gene expression plays 
a vital role in determining variety and amount of protein produced. There are various 
methods to quantify gene expression, for example microarrays (Agilent or 
Affymatrix) and RNA sequencing. 
 
4.8.2 Gene expression data analysis pipeline 
Aim of gene expression data analysis is to understand changes in gene activities 
across compared groups. Traditional methods focus on gene wise analysis that 
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involves analysis of one gene at a time. Gene expression data analysis pipeline 
involves following steps: 
a. Biological hypothesis 
b. Experimental design 
c. Gene expression data generation 
d. Data pre-processing 
e. Differential gene expression analysis 
 
Tradition approach had major limitations: 
 
1. There can be large number of differentially expressed significant genes without 
unifying biological theme. Interpretation of these long gene lists can be quite a 
challenge. 
2. Furthermore, no single gene might meet the threshold for statistical significance 
because of the noise (difference due to other factors than real biological difference) 
inherent to technology used. 
 
Recently, the focus of Gene expression analysis has shifted from single gene to group of 
genes (gene set) that shares common biological theme. Certain phenotypes are often 
believed to be associated with multiple genes rather than a single gene (Aravind 
Subramanian et al., 2005). Furthermore, analyzing set of genes also averages out errors 
at single gene level and increases the statistical power by combining association signals 
from multiple genes in the same gene set. The approach is called as gene set analysis 
(GSA). GSA methods use gene sets that are defined based on the prior biological 
knowledge. Popular sources of gene sets include Gene Ontology (GO) (Beißbarth & 
Speed, 2004) terms, Molecular Signatures Database (MSigDB) (Liberzon et al., 
2011)and Kyoto Encyclopedia of Genes and Genomes (KEGG) (H. Ogata et al., 1999).  
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4.8.3 Gene ontology 
Gene ontology is structured and controlled vocabulary of functions (GO terms) and 
how these functions are related to each other. The GO Consortium currently has 3 
organism databases - Fly Base (Drysdale & Consortium, 2008),  Mouse Genome 
Informatics (Bult et al., 2008), and the Saccharomyces Genome Database (Ball et al., 
2000). GO database is constantly revised and expanded as knowledge accumulates. 
Annotation in a GO term has a source (experimental evidence) and a database entry 
attributed to it. GO has three categories, i) molecular function (biochemical activity of 
a gene product, ii) biological process (biological function to which the gene or gene 
product contributes and iii) cellular component (the location where the gene product 
can be found or is active).   
 
4.9 Gene set analysis methods 
There are two major types of gene set analysis methods: 
4.9.1 Over-representation analysis 
Over-representation analysis, also called as enrichment analysis, is a technique for 
determining whether a list of gene sets (biological processes in our case) is present 
more than it would be expected in a subset of interesting genes (differentially 
expressed genes in our case). Arbitrary threshold is used to select interesting genes. 
For example, genes with adjusted p-value less than 0.05 can be considered as 
interesting genes. Although this method of GSA is quick and easy to implement, 
results are unstable as they depend on arbitrary threshold. Furthermore, there is 
massive reduction in sensitivity as the association measure is solely based on the 
count of the significantly associated genes (Khatri, Sirota, & Butte, 2012). DAVID, 
Ingenuity, GOstats, AmiGO and GeneGO are example of methods based on this 
approach. 
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4.9.2 Gene set analysis 
Gene set analysis methods are evolved version of over-representation methods. These 
methods are threshold free. Meaning, all the genes included in the experiment is fed to 
the method and thus results are stable. The gene list is first ranked based on some gene 
level statistics like t-scores, correlation or p-values. The ranked gene list is then used 
as input for gene set analysis methods. In this study, we used gene set enrichment 
analysis (GSEA). GSEA is one of the most popular GSA method. 
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4.10 Analysis work flow 
 
Figure 4-1 Analysis workflow. 
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5 RESULT 
5.1 HERV-K proviruses expression analysis 
We considered genes and proviruses detectable if the expression level is equal to or 
greater than normalized read count of 16. There were 13 proviruses with detectable 
expression level common in both nonagenarian and young. Three proviruses were 
specific to old and five proviruses was specific to young (Figure5-1). 
 
 
Figure 5-1 HERV-K proviruses with detectable expression level in nonagenarian and 
young subjects 
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We performed gene set enrichment analysis (GSEA) to identify young and older 
group specific GO based biological processes that are significantly associated with the 
proviruses. GSEA was performed in both nonagenarian and young group separately in 
order to identify age specific GO pathways. Table 5-1 summarizes expression levels 
and enriched GO terms in proviruses among nonagenarian and young. Median 
expression levels of proviruses were calculated in both young and nonagenarian 
groups (Table 5-1).  
 
Table 5-1 Expression of HERV-K (HML-2) provirus in nonagenarian and young with 
GO pathway. 
 
* Number of individuals where HERV-K (HML-2) is expressed (normalized read 
count ≥ 16) 
 
Rest of the analysis will be focused only on provirus 1q22 because it is significantly 
differentially expressed between nonagenarian and young. 
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5.2 GSEA 
 GO pathway associated with provirus 1q22 was compared between nonagenarian and 
young individuals. There were 805 significant GO term enriched in nonagenarian and 
46 significant GO term enriched in young. We focused on nonagenarian specific 
pathways i.e. 776 GO terms, which will be analyzed further. 
 
Figure 5-2 Distribution of provirus 1q22 related GO terms among nonagenarian and 
young individuals. 
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Table 5-2 Top 20 provirus 1q22 related GO terms specific to nonagenarians. 
 
We investigated the significant GO terms with their relevance to immunity. This was 
achieved by investigating proportion of immunity related genes in each of the GO 
terms. We used innateDB database (Breuer et al., 2013) as reference for immunity 
related genes. We calculated simple overlap of immunity related genes between 
innateDB genes and GO term member genes. We found six GO terms with 50 percent 
immunity related genes. 
 
 
Table 5-3 GO term with 50 percent of overlap with immunity gene GO term of 1q22   
(nonagenarian specific) 
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5.3 Over-representation Analysis 
GSEA provided nonagenarian specific profile of biological processes associated with 
provirus 1q22. However, directionality of immune related biological processes, which 
is the main question of this study, remains unanswered. In other words, whether 
immune related biological processes are up or down regulated is not inferred. We 
elucidated that information with over-representation analysis. 
 
5.4 Differential expression analysis 
Differential gene expression analysis was done to identify genes that are significantly 
differentially expressed between nonagenarian and young individuals. Fifteen hundred 
and eighty-four genes were differentially expressed between nonagenarian and young 
adults (P < 0.05). Among the differentially expressed genes, 673 were upregulated 
while 911 were down regulated in nonagenarian. The top 20 most significantly 
differentially expressed genes are shown in Table 5-4. 
 
 
Table 5-4 Top 20 genes with the most significant differential expression 
 
Rank Ensembl Gene ID Gene Symbol Gene Description P- value Gene feature
1 ENSG00000173114 LRRN3 Leucine-rich repeat neuronal protein 3 1.327032e-07 down
2 ENSG00000104660 LEPROTL1 Leptin receptor overlapping transcript-like 1 2.168289e-07 up
3 ENSG00000174807 CD248 (Tumor endothelial marker 1) (CD antigen CD248) 2.296232e-07 down
4 ENSG00000166669 ATF7IP2 Activating transcription factor 7-interacting protein 2 5.223306e-07 up
5 ENSG00000115687 PASK PAS domain-containing serine/threonine-protein kinase 8.643576e-07 down
6 ENSG00000164300 SERINC5 Serine incorporator 5 9.745879e-07 up
7 ENSG00000137054 POLR1E DNA-directed RNA polymerase I subunit RPA49 1.863813e-06 up
8 ENSG00000047634 SCML1 Sex comb on midleg-like protein 1 1.895650e-06 down
9 ENSG00000103064 SLC7A6 Cationic amino acid transporter 1.953292e-06 up
10 ENSG00000129270 MMP28 Matrix metalloproteinase 28 2.474790e-06 down
11 ENSG00000136153 LMO7 LIM domain only protein 7 3.206203e-06 down
12 ENSG00000170365 SMAD1 Mothers against decapentaplegic homolog 1 3.390027e-06 up
13 ENSG00000112394 SLC16A10 Monocarboxylate transporter 10 3.877464e-06 down
14 ENSG00000157978 LDLRAP1 Low density lipoprotein receptor adapter protein 1 4.653414e-06 up
15 ENSG00000139998 RAB15 Ras-related protein Rab-15 4.792945e-06 down
16 ENSG00000154153 RETREG1 Reticulophagy regulator 1 5.507027e-06 down
17 ENSG00000136111 TBC1D4 C1 domain family member 4 5.675065e-06 down
18 ENSG00000116771 AGMAT Agmatinase, mitochondrial, EC 3.5.3.11 6.487382e-06 down
19 ENSG00000143167 GPA33 Cell surface A33 antigen 6.885712e-06 down
20 ENSG00000182183 SHISAL2A Protein shisa-like-2A 7.095193e-06 down
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Among the proviruses, HML-2_1q22, HML-2_10p14, and HML-2_8p23.1a (hereafter 
referred as 1q22, 10p14, and 8p23.1a respectively) were significantly differentially 
expressed. We focus only on those genes that are highly positively or negatively 
correlated with the differentially expressed proviruses. 
 
Figure 5-3 Expression levels of differentially expressed proviruses. 
 
 
5.5 1q22 specific over-representation analysis  
5.5.1 Correlation analysis 
Based on our results, 347/1584 differentially expressed genes were highly correlated 
(>0.80) with provirus 1q22 (positively: 178, negatively: 169). Table 5-5 shows the top 
20 of the highly correlated genes. 
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Table 5-5 Top 20 differentially expressed genes that are highly correlated with 
provirus 1q22 
 
 
 
5.5.2 Overlap with existing database 
We investigated overlap between the interesting genes identified in our study with 
existing literature. For that purpose, we analyzed genes that are directly involved in 
immunological processes from innate database (Breuer et al., 2013). We identified that 
30/347 1q22 correlated genes have also been reported as immune related genes in innate 
database. Twenty-one of the genes were positively correlated with 1q22, while nine of 
them were negatively correlated (Figure 5-4). 
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Figure 5-4 Overlap analysis between differentially expressed genes that are highly 
correlated with 1q22 and immune genes in innateDB 
 A. Overlap between immunity genes in innateDB and differentially expressed genes 
that are positively correlated with 1q22. B. Overlap between immunity genes in 
innateDB and differentially expressed genes that are negatively correlated with 1q22. 
 
 
 
5.5.3 Pathways analysis with positively correlated genes 
We identified 265 biological processes related GO terms significantly enriched (fdr < 
0.05) in 1q22 positively correlated genes. Table 5-6 shows the top 20 GO terms. 
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Table 5-6 Top 20 biological processes related GO terms associated with differentially 
expressed genes that are positively correlated with provirus 1q22. 
 
 
 
5.5.4 Pathways analysis with negatively correlated genes 
We identified 39 biological processes related GO terms significantly enriched (fdr < 
0.05) in 1q22 negatively correlated genes. Table 5-7 shows the top 20 GO terms. 
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Table 5-7 Top 20 biological processes related GO terms associated with differentially 
expressed genes that are negatively correlated with provirus 1q22. 
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6 DISCUSSION  
Immunosenescence leads to increased incident and severity of various infections, 
reactivation of latent viruses and decline in vaccine responses among the elderly. As 
the proportion of older population is rising sharply across the globe, 
immunosenescence is an emerging public health problem. Fundamental understanding 
of immunosenescence is thus vital for prevention, control, and treatment of ageing-
related diseases among the vulnerable population. Immunosenescence has been known 
to be induced by pathogens like CMV. Interestingly, HERV-K has been shown to be 
co-expressed with CMV in several diseases and cancers (See Section 1). Thus, it is 
rational to hypothesize that HERV-K might have role in induction of 
immunosenescence.  
 
GSEA in our study revealed various nonagenarian specific GO terms that are 
correlated with provirus 1q22. This include several immunity related GO terms such 
as antigen processing and presentation of exogenous peptide antigen via MHC class I 
and class II, innate immune response activating cell surface receptor signalling 
pathway and Fc-gamma receptor-signalling pathway involved in phagocytosis. 
Metabolic process pathway such as regulation of cellular amino acid metabolic 
process, regulation of cellular amine metabolic process, cellular amine metabolic 
process, vascular transport, and amine metabolic process were also highly enriched in 
nonagenarian (Table 5-2). Overlap analysis between innateDB genes and 1q22 GO 
terms revealed six GO terms that consist at least 50% immunity related genes. The 
GO terms were related to Myd88 dependent toll like receptor signalling pathway, 
neutrophil chemotaxis, and migration, positive regulation of interleukin-6 production 
and phagocytosis. Study by  Kovacs et al., 2010 suggested that interleukin-6 is a 
crucial factor in maintaining the age-related defects in macrophages through 
transformation of proinflammatory cytokines.  A study showed that neutrophils from 
elderly migrated with similar chemokinesis as in young but with less accuracy (Sapey 
et al., 2014).  
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Our differential gene expression analysis revealed several human genes and three 
HERV-K proviruses (1q22, 10p14, and 8p23.1a) significantly differentially expressed 
between nonagenarian and young. However, as the focus of this study was to 
investigate role of HERV-K proviruses in immunosenescence, we analysed only the 
genes that are highly correlated with the proviruses. We hypothesized that the 
proviruses play role in immunosenescence by regulating the highly correlated genes. 
Interestingly, 30 of the differentially expressed genes that were highly correlated with 
1q22 have also been reported as immune related genes in innate database (Breuer et 
al., 2013). This suggests that provirus 1q22 and correlated genes potentially play role 
in immunosenescence. Among the top 20 correlated genes presented in Table 5-5 (see 
Results Section), genes ITGA6, TCF7 and TNFRSF10A are present as immune 
related genes in innate database. ITGA6 and TCF7 are down regulated while 
TNFRSF10A is up regulated in nonagenarian. ITGA6 is expressed in immune cell 
such as appendix, spleen, and lymph node. Studies have shown elevated level of  
ITGA6 in different tumour cells (Jin et al., 2018; Kwon et al., 2013; Yamakawa, 
Kaneda, Saito, Ichihara, & Morishita, 2012). Furthermore, studies have shown that 
immunosenescence may contribute to increasing incidence of most cancers among 
elderly (Pawelec, 2017). TCF7 plays an important role in providing protective 
immunity after resolution of acute infections (Jeannet et al., 2010; Utzschneider et al., 
2016; Zhou et al., 2010). TNFSF10 plays role in immune surveillance (Shin, Kang, 
Lee, & Kim, 2016). Immune surveillance is a mechanism of immune system to 
recognize and destroy invading pathogens but also host cell that become cancerous 
(Swann et al., 2007). Gene LEPROTL1, the most significant gene with provirus 1q22, 
negatively regulates growth hormone receptor (Touvier et al., 2009). Growth hormone 
is an important hormone, which effect immune system that decreases with age (Taub, 
Murphy, & Longo, 2010).   
 
Various studies have shown that provirus 1q22 is upregulated in HIV patients 
(Brinzevich et al., 2014; Laderoute et al., 2007; Laderoute, Larocque, Giulivi, & Diaz-
Mitoma, 2015). HIV causes immune suppression. If provirus 1q22 is upregulated in 
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HIV patients pertaining to immune suppression, it is rational to think that the provirus 
might also be upregulated in older people for similar reason. Furthermore, provirus 
1q22 are able to encode complete env protein (Flockerzi et al., 2008) that has 
superantigenic property (Sutkowski et al., 2004). Superantigens cause non-specific 
activation of T cell causing polyclonal, antigen receptor independent activation of 
lymphocytes (Huber, Hsu, & Sutkowski, 1996). Expression of the superantigen is 
elevated in autoimmune diseases like rheumatoid arthritis (Sicat, Sutkowski, & Huber, 
2005). Hence, it is possible that the superantigen contritbes to the development of 
autoimmune inflammatatory disease which goes alongside of the process of 
immunosenescence in elderly.  
 
Two hundred and sixty five biological processes related GO terms were identified to 
be significantly enriched in genes positively correlated with 1q22. Similarly, we 
identified 39 biological processes related GO terms significantly enriched in genes 
negatively correlated with 1q22. As the three proviruses are upregulated in 
nonagenarian, genes that are positively correlated with proviruses are upregulated and 
those that are negatively correlated are downregulated in nonagenarian. The 
upregulated biological pathways are related to response to wound healing, 
phagocytosis, cell adhesion, immunity (eg., neutrophil mediated immunity, and 
myeloid leukocyte mediated immunity) regulation of vesicle mediated transportion, 
positive regualtion of endocytosis and regualtion of cell to cell adhesion. Studies have 
shown that there is no reduction in the neutrophil number with age (Butcher et al., 
2000). Thus, there is no loss in the ability to generate neutrophil mediated response 
towards infections (Beerman et al., 2010). Furthermore, a study reported that larger 
number of neutrophils are needed  for wound healing in older mice than in younger 
mice (Nishio, Okawa, Sakurai, & Isobe, 2008). Pathways that are seen to be 
upregulated in elderly are related with neutrophil mediated immunity. Pathways 
related to lymphocyte differentiation and proliferation are found to be downregulated 
in elderly, indicating lower response of aged lymphoid cell in elderly.  It has been 
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suggested that reduced capability of lymphocyte to proliferate is one of the crucial age 
related change in immune system (Linton & Dorshkind, 2004).  
 
 
This study is based on PBMC as it contains important cell type such as lymphocytes 
and monocytes needed for the analysis. Furthermore, the study uses freshly isolated 
PBMCs without any vitro activation, which probably represents the true in-vivo 
situation and therefore be useful to investigate the significance of the various effects 
of HERV-K.  
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7 CONCLUSION 
We performed transcription-based analysis to uncover potential role of HERV-K 
proviruses in immunosenescence. GSEA analysis was done using correlation scores 
calculated between human genes and provirus to profile nonagenarian specific 
biological process related GO terms. We further, analysed differntial gene expression 
between young and nonagenarian groups. We also  performed over-representation 
analysis (Gostats) with only those significant genes that are hightly correlated with 
HERV-K provirus 1q22 (cor < -0.80 or > 0.80). The study identified several immunity 
related genes and biological processes significantly associated with HERV-K provirus 
1q22. Our results suggest that proviruse 1q22 is potential factor in mediating 
immunosenescence. Therefore, further research with larger datasets with gender 
variation is needed for deeper understanding.  
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